CRISPR Therapeutics AG

CRISPR Therapeutics AG Stock

—P/E
€3.44BMarket capitalisation
-US$4.73Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), whichis a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

CRISPR Therapeutics AG is registered in the following country: Switzerland (Exchange: USNASD).

Key metrics

Key metrics and master data for the CRISPR Therapeutics AG stock.

Market capitalisation
€3.44B
P/E
—
P/B
2.32
P/S
163.93
P/CF
-10.11
Issued shares 97M Units

Return

Here you can see the performance of the CRISPR Therapeutics AG stock.

PeriodPerfor­mance
1 Week-9.32 %
1 Month-19.02 %
3 Months+7.40 %
6 Months-6.25 %
1 Year-23.91 %
YTD-6.86 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the CRISPR Therapeutics AG share.

DateRatio
No data available.

Which ETF contains the CRISPR Therapeutics AG stock?

The CRISPR Therapeutics AG stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, CRISPR Therapeutics AG has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the CRISPR Therapeutics AG stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.